Suppr超能文献

Rho-kinase 在压力超负荷诱导的小鼠右心室肥厚和功能障碍中的关键作用。

Crucial role of rho-kinase in pressure overload-induced right ventricular hypertrophy and dysfunction in mice.

机构信息

From the Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan (S.I., K.S., N.K., S.M., K.S., J.O., T.S., Y.F., Y.S., H.S.); and Department of Molecular Genetics, Institute of Biomedical Sciences, Fukushima Medical University School of Medicine, Fukushima, Japan (Ke. Kobayashi, Ka. Kobayashi).

出版信息

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1260-71. doi: 10.1161/ATVBAHA.114.303320. Epub 2014 Mar 27.

Abstract

OBJECTIVE

Right ventricular (RV) failure is the leading cause of death in various cardiopulmonary diseases, including pulmonary hypertension. It is generally considered that the RV is vulnerable to pressure overload as compared with the left ventricle (LV). However, as compared with LV failure, the molecular mechanisms of RV failure are poorly understood, and hence therapeutic targets of the disorder remain to be elucidated. Thus, we aimed to identify molecular therapeutic targets for RV failure in a mouse model of pressure overload.

APPROACH AND RESULTS

To induce pressure overload to respective ventricles, we performed pulmonary artery constriction or transverse aortic constriction in mice. We first performed microarray analysis and found that the molecules related to RhoA/Rho-kinase and integrin pathways were significantly upregulated in the RV with pulmonary artery constriction compared with the LV with transverse aortic constriction. Then, we examined the responses of both ventricles to chronic pressure overload in vivo. We demonstrated that compared with transverse aortic constriction, pulmonary artery constriction caused greater extents of mortality, Rho-kinase expression (especially ROCK2 isoform), and oxidative stress in pressure-overloaded RV, reflecting the weakness of the RV in response to pressure overload. Furthermore, mice with myocardial-specific overexpression of dominant-negative Rho-kinase showed resistance to pressure overload-induced hypertrophy and dysfunction associated with reduced oxidative stress. Finally, dominant-negative Rho-kinase mice showed a significantly improved long-term survival in both pulmonary artery constriction and transverse aortic constriction as compared with littermate controls.

CONCLUSION

These results indicate that the Rho-kinase pathway plays a crucial role in RV hypertrophy and dysfunction, suggesting that the pathway is a novel therapeutic target of RV failure in humans.

摘要

目的

右心室(RV)衰竭是各种心肺疾病(包括肺动脉高压)导致死亡的主要原因。与左心室(LV)相比,通常认为 RV 容易受到压力超负荷的影响。然而,与 LV 衰竭相比,RV 衰竭的分子机制尚不清楚,因此该疾病的治疗靶点仍有待阐明。因此,我们旨在确定压力超负荷小鼠模型中 RV 衰竭的分子治疗靶点。

方法和结果

为了对各自的心室施加压力超负荷,我们在小鼠中进行了肺动脉缩窄或升主动脉缩窄。我们首先进行了微阵列分析,发现与 RhoA/Rho-激酶和整合素途径相关的分子在肺动脉缩窄的 RV 中与升主动脉缩窄的 LV 相比显著上调。然后,我们在体内检查了两个心室对慢性压力超负荷的反应。我们证明,与升主动脉缩窄相比,肺动脉缩窄导致更大程度的死亡率、Rho-激酶表达(尤其是 ROCK2 同工型)和压力超负荷 RV 中的氧化应激,反映了 RV 对压力超负荷的反应较弱。此外,心肌特异性过表达显性失活 Rho-激酶的小鼠对压力超负荷诱导的肥厚和功能障碍具有抵抗力,与氧化应激减少有关。最后,与同窝对照相比,显性失活 Rho-激酶小鼠在肺动脉缩窄和升主动脉缩窄中均表现出显著改善的长期存活率。

结论

这些结果表明 Rho-激酶途径在 RV 肥厚和功能障碍中起关键作用,表明该途径是人类 RV 衰竭的新治疗靶点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验